Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- JILL -46.1%, (J. Jill issues downside Q3 guidance citing lower than expected sales trend across both our retail and direct channels),NSTG -9.8%, HAWK -8.6%, DPZ -6.2%, LSCC -4.3%, RIC -4.1%, JCOM-3%, T -1.8%, (reiterating 2017 guidance of mid-single digit adj earnings growth (vs +3.8% CapIQ estimate), adjusted op margin expansion, CapEx in $22 billion range and free cash flow at low end of $18 bln range), LNN -1.1%, ATI -0.8%
Other news:
- ACRX -59.8% (receives Complete Response Letter from the FDA regarding its New Drug Application for DSUVIA
- TRVN -11.8% (to streamline operations to focus on approval and commercial launch of OLINVO; halting its investment in early stage research)
- PTGX -11.7% (prices 3.53 mln shares of common stock at $17.00 per share)
- HMNY -10% (affirms satisfying MoviePass transaction financing condition, increases investment in MoviePass and acquires option for additional investment; also Forbes yesterday reported that MoviePass is having difficulties servicing customers following the August ramp up )
- KNDI -6.1% (files for $300 mln mixed securities shelf offering)
- AZRX -4.4% (thinly traded; files for $10 mln mixed securities shelf offering)
- CHS -4% (light volume; following J Jill guidance)
- KL -3% (Kirkland Lake Gold reports Q3 gold production +4% y/y (+29% excluding production from mines currently on care/maintenance); on track to achieve improved full-year 2017 guidance of 570,000-590,000 ounces)
- GM -2% (reports that company may idle a Detroit factory amid slowing demand)
- SRNE -1.4% (continued strength after 48% move higher today)
- CSCO -1.2% (following JNPR guidance)
- F -0.9% (in sympathy with GM)
Analyst comments:
- VIAB -2.4% (downgraded to Neutral from Buy at Guggenheim)
- WSM -1.9% (downgraded to Underperform from Neutral at Credit Suisse )
- MNRO -1.6% (downgraded to Hold from Buy at Jefferies)
- DIS -0.9% (downgraded to Neutral from Buy at Guggenheim)